Thomas Karsten Kilvær
Nikita,
Anders,
Masoud,
Lill-Tove Rasmussen,
Stig Manfred,
Kajsa
et al.:
Fast TILs—A pipeline for efficient TILs estimation in non-small cell lung cancer
Journal of Pathology Informatics 01. April 2025 DOI
Susanne,
Thomas Karsten,
Agnethe
:
Adult epilepsy in a North Norwegian County – incidence, prevalence, clinical features, and mortality (2012-2022)
Seizure 2025 DOI
Heidi,
Are Martin,
Ragnhild Sørum,
Thomas Karsten,
Tone Marte,
Christopher
et al.:
A Digital Outpatient Service With a Mobile App for Tailored Care and Health Literacy in Adults With Long-Term Health Service Needs: Multicenter Nonrandomized Controlled Trial
Dagny,
Thomas Karsten,
Mona Irene,
Egil Støre,
Ilona Halva,
Erna-Elise
et al.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Hallgeir,
Lill-Tove Rasmussen,
Sigve,
Mona Irene,
Ana Paola,
Thomas Karsten
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
Erna-Elise,
Sigve,
Mehrdad,
Mona Irene,
Ana Paola,
Mette
et al.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad,
Sigve,
K.,
Erna-Elise,
Thomas Karsten,
Lill-Tove Rasmussen
et al.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Hallgeir,
Sigve,
Mona Irene,
Ana Paola,
Lill-Tove Rasmussen,
Thomas Karsten
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
Nikita,
Morten,
Edvard,
Kajsa,
Lill-Tove Rasmussen,
Ruth
et al.:
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
Hallgeir,
Lill-Tove Rasmussen,
Sigve,
Roy M.,
Thomas Karsten
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
Maria Jenvin,
Sigve,
Mehrdad,
Mona I.,
Lise Martine,
Tom
et al.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Maria Jenvin,
Sigve,
Mehrdad,
Mona Irene,
Lise Martine,
Roy M.
et al.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Mehrdad,
Thomas Karsten,
Simin,
Thomas,
Erna-Elise,
Marte
et al.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021 DOI
Thomas Karsten,
Erna-Elise,
Sigve,
Mehrdad,
Roy M.,
Lill-Tove Rasmussen
et al.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Mehrdad,
Lill-Tove,
Simin,
Erna-Elise,
Elin,
Sigve
et al.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Thomas Karsten,
Mehrdad,
Turid,
Jørg,
Luigi de,
Tom
et al.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
Kaja Konstanse,
Charles,
Thea K.W.,
Thomas Karsten,
Erna Elise,
Mona Irene
et al.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Mehrdad,
Thomas Karsten,
Stig Manfred,
Elin,
Erna Elise,
Sigurd
et al.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Human Pathology 2018 DOI
Sigurd,
Mehrdad,
Inigo Zubiavrre,
Elin,
Samer,
Erna Elise
et al.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018 DOI
Thomas Karsten,
Mehrdad,
Turid,
Arne,
Carina,
Roy M.
et al.:
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
Erna-Elise,
Thomas Karsten,
Mehrdad,
Elin,
Sigurd,
Sigve
et al.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Samer,
Elin,
Thomas Karsten,
Tom,
Sigve,
Mehrdad
et al.:
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
Kaja,
Thea,
Mehrdad,
Elin,
Tom,
Thomas Karsten
et al.:
Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
Steroids 2016 DOI
Roy M.,
Lill-Tove,
Thomas Karsten,
Sigve,
Elin,
Erna-Elise
et al.:
The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
Journal of Thoracic Oncology 2016 DOI
Tom,
Thomas Karsten,
Sigve,
Elin,
Erna-Elise,
Sigurd
et al.:
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
Annals of Oncology 2016 DOI
Mehrdad,
Lill-Tove,
Erna-Elise,
Elin,
Samer,
Sigve
et al.:
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
Erna-Elise,
Thomas Karsten,
Mehrdad,
Samer,
Sigurd,
Sigve
et al.:
Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
Thomas Karsten,
Erna-Elise,
Mehrdad,
Samer,
Ramona Johansen,
Khalid
et al.:
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
Thomas Karsten,
Mehrdad,
Turid,
Samer,
Erna-Elise,
Roy M.
et al.:
Cancer associated fibroblasts in stage I-IIIA NSCLC: Prognostic impact and their correlations with tumor molecular markers
Sigurd,
Yury,
Samer,
Elin,
Charles,
Marte
et al.:
Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
Tom,
Sigurd,
Erna-Elise,
Elin,
Samer,
Thomas Karsten
et al.:
Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer
Clinical Cancer Research 2015 DOI
Erna-Elise,
Thomas Karsten,
Mehrdad,
Ramona Johansen,
Samer,
Sigurd
et al.:
CD45RO+ memory T lymphocytes – a candidate marker for TNM-immunoscore in squamous non-small cell lung cancer
Thomas Karsten,
Erna-Elise,
Sigurd,
Tom,
Roy M.,
Lill-Tove
et al.:
Lymphangiogenic markers and their impact on nodal metastasis and survival in non-small cell lung cancer - A structured review with meta-analysis
Thomas Karsten,
Eivind,
Andrey Yurjevich,
Sveinung Wergeland,
Roy M.,
Lill-Tove
et al.:
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
Sveinung Wergeland,
Thomas Karsten,
Andrey Yurjevich,
Tom,
Eivind,
Khalid
et al.:
Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
Eivind,
Thomas Karsten,
Sveinung Wergeland,
Andrey Yurjevich,
Sigve,
Roy M.
et al.:
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
Sveinung Wergeland,
Thomas Karsten,
Andrey Yurjevich,
Tom,
Eivind,
Khalid
et al.:
Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
Sveinung Wergeland,
Thomas Karsten,
Andrey Yurjevich,
Tom,
Eivind,
Khalid Ibrahim
et al.:
High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator
Sveinung Wergeland,
Thomas Karsten,
Andrey Yurjevich,
Tom,
Eivind,
Khalid Ibrahim
et al.:
Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
Sveinung Wergeland,
Thomas Karsten,
Andrey Yurjevich,
Tom,
Eivind,
Khalid Ibrahim
et al.:
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
Sveinung Wergeland,
Thomas Karsten,
Andrey Yurjevich,
Tom,
Eivind,
Khalid Ibrahim
et al.:
Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
Thomas Karsten,
Andrey Yurjevich,
Sveinung Wergeland,
Eivind,
Roy M.,
Lill-Tove
et al.:
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients
Andrey Yurjevich,
Sveinung Wergeland,
Thomas Karsten,
Tom,
Eivind,
Roy M.
et al.:
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas
International Journal of Oncology 2011 DOI
Anne,
Nikita,
Thomas Karsten
:
Studie: Slik kan AI revolusjonere lungekreftbehandling
VG : Verdens gang 2025
Heidi,
Are Martin,
Thomas Karsten,
Tone Marte,
Lars-Petter Ness,
Christopher
et al.:
Digital Outpatient Services for Adults: Development of an Intervention and Protocol for a Multicenter Non-Randomized Controlled Trial
Heidi,
Anna,
Christopher,
Are Martin,
Thomas Karsten,
Lotte Sandberg
et al.:
Digital outpatient services: development of an intervention and a multicenter controlled trial
2022
Heidi,
Anna,
Christopher,
Are Martin,
Saida Alfrida Martinez,
Lotte Sandberg
et al.:
Digital poliklinikk - utvikling av en intervensjon og en multisenterstudie
2022
Kaja Konstanse,
Thea K.W.,
Mehrdad,
Elin,
Tom,
Thomas Karsten
et al.:
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
Steroids 2018 DOI
Sigurd,
Yury,
Samer,
Elin Helmine,
Charles Walquist,
Marte
et al.:
Erratum: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. [BMC Cancer. 15, (2015) (441)] DOI: 10.1186/s12885-015-1446-z
BMC Cancer 2016 DOI
Yury,
Andrey Yurjevich,
Lill-Tove,
Roy M.,
Igor,
Ingvild
et al.:
Transcription factor PAX6 is expressed in human soft tissue sarcomas and confers negative impact on patients' survival
2014
The 50 latest publications is shown on this page. See all publications in Cristin here →